Skip to main content

Ingenuity Licenses Pathway Analysis Software to Schering-Plough Research Institute

NEW YORK, Oct. 12 (GenomeWeb News) - Schering-Plough Research Institute has licensed pathway analysis software from Ingenuity, the Redwood City, Calif.-based bioinformatics company said today.


Under the agreement, researchers at the institute will have access to Ingenuity Pathway Analysis 3.0 and Ingenuity Pathways Analysis Integration Module.


The company's Pathway Analysis product allows scientists to create and analyze custom networks for targets, biomarkers, disease areas, and processes.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.